These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25822686)

  • 21. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
    Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
    Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.
    Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
    Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
    Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
    World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer.
    Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY
    Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
    PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel methylation gene panel in adjacent normal tissues predicts poor prognosis of colorectal cancer in Taiwan.
    Hsu CH; Hsiao CW; Sun CA; Wu WC; Yang T; Hu JM; Huang CH; Liao YC; Chen CY; Lin FH; Chou YC
    World J Gastroenterol; 2020 Jan; 26(2):154-167. PubMed ID: 31988582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
    Han SW; Lee HJ; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
    Int J Cancer; 2013 May; 132(9):2209-16. PubMed ID: 23034738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer.
    Li M; Zhu C; Xue Y; Miao C; He R; Li W; Zhang B; Yu W; Huang X; Lv M; Xu Y; Huang Q
    Br J Cancer; 2023 May; 128(9):1681-1689. PubMed ID: 36828869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer.
    Wiley A; Katsaros D; Fracchioli S; Yu H
    Int J Gynecol Cancer; 2006; 16(1):210-8. PubMed ID: 16445635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
    Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
    J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA.
    Wang W; Zhu X; Zhang X; Lei C; Zeng Z; Lan X; Cui W; Wang F; Xu S; Zhou J; Wu X; Deng H; Li X; Fan J; Ding Y; Huang Z; Liang L
    J Pathol; 2023 Apr; 259(4):376-387. PubMed ID: 36573552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence.
    Herbst A; Wallner M; Rahmig K; Stieber P; Crispin A; Lamerz R; Kolligs FT
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):565-9. PubMed ID: 19282772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
    Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
    Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical stage and risk of recurrence and mortality: interaction of DNA methylation factors in patients with colorectal cancer.
    Chang HF; Wu CC; Sun CA; Chu CM; Lin FG; Hsieh JF; Hsu CH; Huang CH; Yang T; Tsai YM; Kuan JC; Chou YC
    J Investig Med; 2016 Oct; 64(7):1200-7. PubMed ID: 27296458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma.
    Messerini L; Cianchi F; Cortesini C; Comin CE
    Hum Pathol; 2006 Oct; 37(10):1259-67. PubMed ID: 16949928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial-Specific SHP1-P2 Methylation - a Novel Universal Tumor Marker for Detection of Colorectal Cancer Lymph Node Metastasis.
    Rattanatanyong P; Keelawat S; Kitkumthorn N; Mutirangura A
    Asian Pac J Cancer Prev; 2016; 17(8):4117-23. PubMed ID: 27644671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.